comparemela.com

Page 39 - Licensing Agreements News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

By Rob Curran Biotech company Beam Therapeutics struck a deal with Eli Lilly to sell to the drug giant certain rights in its cardiovascular-disease.

United kingdomRuth gimenoRob curranEli lillyBeam therapeuticsVerve therapeuticsNobel prize winning crisprArticle normalBiotechnology servicesHealthcare life sciencesBiological therapyHealthcare provisionOwnership changesAcquisitions mergers shareholdingsContracts ordersNon government contracts orders

BioLineRx Shares Rise 12% After Licensing Agreement for Motixafortide

By Chris Wack BioLineRx shares were up 12% to $1.49 after the company entered an exclusive license agreement with Guangzhou Gloria Biosciences Co. and an.

Chris wackGuangzhou gloria biosciences coGuangzhou gloria biosciencesArticle normalHealthcare life sciencesFinancial performanceShare price movement disruptionsContracts ordersNon government contracts ordersLicensing agreementsCorporate industrial newsEquity marketsCommodity financial market newsContent typesFactiva filtersC amp ampe exclusion filter

ABVC Shares More than Triple on Licensing Deal

By Rob Curran Shares of ABVC BioPharma more than tripled after the development-stage biopharmaceutical company struck a licensing agreement with AiBtl.

Rob curranAibtl biopharmaBtl biopharmaArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceOwnership changesAcquisitions mergers shareholdingsNew products servicesContracts ordersNon government contracts ordersLicensing agreementsCorporate actionsCorporate industrial newsProducts services

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSoult ukpyolsiSouth koreaIsrael generalCity ofUnited kingdomNew south walesNew zealandSan franciscoDana farber cancer instituteNorth carolinaHong kongMemorial sloan kettering cancer centerUniversity of utahDistrict of columbia

Health Care Down Amid Mixed Earnings -- Health Care Roundup

Health-care companies fell amid mixed earnings. Merck shares rose after the Big Pharma concern reported third-quarter results that topped analysts'.

Rob curranAibtl biopharmaBig pharmaPharmaceutical servicesArticle normalMedical equipment suppliesHealthcare life sciencesSpecialized drugs medicationsFinancial performanceContracts ordersNon government contracts ordersLicensing agreementsCorporate industrial newsPolitical general newsContent typesFactiva filters

vimarsana © 2020. All Rights Reserved.